Literature DB >> 33926045

Moderating Effects of BDNF Genetic Variants and Smoking on Cognition in PTSD Veterans.

Gordana Nedic Erjavec1, Matea Nikolac Perkovic1, Lucija Tudor1, Suzana Uzun2,3, Zrnka Kovacic Petrovic2,4, Marcela Konjevod1, Marina Sagud4,5, Oliver Kozumplik2,3, Dubravka Svob Strac1, Tina Peraica6, Ninoslav Mimica2,4, Ana Havelka Mestrovic7, Denis Zilic8, Nela Pivac1.   

Abstract

Posttraumatic stress disorder (PTSD) is frequently associated with cognitive disturbances and high prevalence of smoking. This study evaluated cognition in war veterans with PTSD and control subjects, controlled for the effect of smoking and brain derived neurotrophic factor (BDNF) rs6265 and rs56164415 genotypes/alleles. Study included 643 male war veterans with combat related PTSD and 120 healthy controls. Genotyping was done by real time PCR. Cognitive disturbances were evaluated using the Positive and Negative Syndrome Scale (PANSS) cognition subscale and the Rey-Osterrieth Complex Figure (ROCF) test scores. Diagnosis (p < 0.001), BDNF rs56164415 (p = 0.011) and smoking (p = 0.028) were significant predictors of the cognitive decline in subjects with PTSD. BDNF rs56164415 T alleles were more frequently found in subjects with PTSD, smokers and non-smokers, with impaired cognition, i.e., with the higher PANSS cognition subscale scores and with the lower ROCF immediate recall test scores. Presence of one or two BDNF rs56164415 T alleles was related to cognitive decline in PTSD. The T allele carriers with PTSD had advanced cognitive deterioration in smokers and nonsmokers with PTSD, and worse short-term visual memory function. Our findings emphasize the role of the BDNF rs56164415 T allele and smoking in cognitive dysfunction in war veterans with PTSD.

Entities:  

Keywords:  BDNF rs56164415; BDNF rs6265; PTSD; cognition; smoking; war veterans

Year:  2021        PMID: 33926045     DOI: 10.3390/biom11050641

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  99 in total

1.  Posttraumatic stress disorder and cigarette smoking: A systematic review.

Authors:  Nathan T Kearns; Emily Carl; Aliza T Stein; Anka A Vujanovic; Michael J Zvolensky; Jasper A J Smits; Mark B Powers
Journal:  Depress Anxiety       Date:  2018-09-07       Impact factor: 6.505

2.  The Effects of a BDNF Val66Met Polymorphism on Posttraumatic Stress Disorder: A Meta-Analysis.

Authors:  Kaitlin E Bountress; Silviu-Alin Bacanu; Rachel L Tomko; Kristina J Korte; Terrell Hicks; Christina Sheerin; Mackenzie J Lind; Marisa Marraccini; Nicole Nugent; Ananda B Amstadter
Journal:  Neuropsychobiology       Date:  2018-06-06       Impact factor: 2.328

3.  Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Robert H Pietrzak; Risë B Goldstein; Steven M Southwick; Bridget F Grant
Journal:  J Anxiety Disord       Date:  2010-11-26

4.  Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han.

Authors:  Hui Yu; Zhijun Zhang; Yongmei Shi; Feng Bai; Chunming Xie; Yun Qian; Yonggui Yuan; Linglong Deng
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

5.  Significant association between catechol-O-methyltransferase (COMT) Val158/108Met polymorphism and cognitive function in veterans with PTSD.

Authors:  Ana Havelka Mestrovic; Lucija Tudor; Matea Nikolac Perkovic; Gordana Nedic Erjavec; Zrnka Kovacic Petrovic; Dubravka Svob Strac; Marcela Konjevod; Nela Pivac
Journal:  Neurosci Lett       Date:  2017-12-14       Impact factor: 3.046

6.  BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory study.

Authors:  Kristina F Zdanys; Timothy G Kleiman; Huiping Zhang; Fatih Ozbay; Martha G MacAvoy; Joel Gelernter; Christopher H van Dyck
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 7.  Risk factors for posttraumatic stress disorder: An umbrella review of systematic reviews and meta-analyses.

Authors:  Miquel Tortella-Feliu; Miquel A Fullana; Ana Pérez-Vigil; Xavier Torres; Jacobo Chamorro; Sergio A Littarelli; Aleix Solanes; Valentina Ramella-Cravaro; Ana Vilar; José A González-Parra; Raül Andero; Abraham Reichenberg; David Mataix-Cols; Eduard Vieta; Paolo Fusar-Poli; John P A Ioannidis; Murray B Stein; Joaquim Radua; Lorena Fernández de la Cruz
Journal:  Neurosci Biobehav Rev       Date:  2019-09-11       Impact factor: 8.989

8.  The Analysis of Two BDNF Polymorphisms G196A/C270T in Chinese Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Lianping Xu; Danyang Tian; Jiao Li; Lu Chen; Lu Tang; Dongsheng Fan
Journal:  Front Aging Neurosci       Date:  2017-05-10       Impact factor: 5.750

9.  Peripheral blood levels of brain-derived neurotrophic factor in patients with post-traumatic stress disorder (PTSD): A systematic review and meta-analysis.

Authors:  Helia Mojtabavi; Amene Saghazadeh; Leigh van den Heuvel; Joana Bucker; Nima Rezaei
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

10.  Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease.

Authors:  Cinzia Costa; Carmelo Sgobio; Sabrina Siliquini; Alessandro Tozzi; Michela Tantucci; Veronica Ghiglieri; Massimiliano Di Filippo; Valentina Pendolino; Antonio de Iure; Matteo Marti; Michele Morari; Maria Grazia Spillantini; Emanuele Claudio Latagliata; Tiziana Pascucci; Stefano Puglisi-Allegra; Fabrizio Gardoni; Monica Di Luca; Barbara Picconi; Paolo Calabresi
Journal:  Brain       Date:  2012-05-04       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.